Vietnam External Counterpulsation Devices Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Vietnam External Counterpulsation Devices Market Overview

• The Vietnam External Counterpulsation Devices Market is valued at approximately USD 15 million, based on a five-year historical analysis of external counterpulsation and broader cardiovascular device adoption in the country. This growth is primarily driven by the increasing prevalence of cardiovascular diseases, which account for around 31–33 percent of all deaths in Vietnam, rising healthcare expenditure, and advancements in medical technology. The demand for non-invasive treatment options, such as external counterpulsation, has surged as patients and healthcare providers seek effective alternatives to traditional surgical interventions, particularly for stable angina and heart failure management.
• Key cities such as Ho Chi Minh City and Hanoi dominate the market due to their advanced healthcare infrastructure and concentration of medical facilities. These urban centers host major tertiary hospitals and cardiac centers such as Bach Mai Hospital, National Heart Institute in Hanoi, and Cho Ray Hospital and HCMC University Medical Center in Ho Chi Minh City, which are at the forefront of adopting advanced cardiology technologies and interventional techniques. These hospitals and clinics are increasingly focusing on modern, less invasive cardiovascular treatment and rehabilitation solutions, supporting the adoption of external counterpulsation devices to enhance patient care and treatment outcomes.
• In 2023, the Vietnamese government implemented regulations to promote the use of advanced medical technologies, including external counterpulsation devices. In particular, external counterpulsation systems fall under the scope of the Medical Device Management Decree No. 98/2021/ND-CP issued by the Government of Vietnam, which standardizes classification, registration, import, quality management, and post-marketing surveillance for medical devices. This decree requires cardiovascular and related therapeutic devices to obtain appropriate market registration, comply with safety and performance standards, and meet labeling and distribution requirements, thereby supporting safer deployment of advanced treatment technologies. The government is also prioritizing cardiovascular disease prevention and early detection within its non?communicable disease strategy, encouraging hospitals to invest in modern cardiology equipment and technologies to improve cardiovascular care and reduce the burden of heart diseases.

Vietnam External Counterpulsation Devices Market Segmentation

By Product Type:The product type segmentation includes Enhanced External Counterpulsation (EECP) Systems, External Counterpulsation Accessories & Consumables, Service & Maintenance Contracts, and Others. Among these, Enhanced External Counterpulsation (EECP) Systems dominate the market due to their effectiveness in improving symptoms in patients with refractory angina and certain heart failure cases, as supported by clinical use globally. The growing awareness of non-invasive treatment options in Vietnam, alongside an increasing number of cardiology and cardiac rehabilitation centers in major cities, is driving demand for these systems. The accessories and consumables segment also plays a significant role, as they are essential for the operation, calibration, and ongoing maintenance of EECP systems, ensuring consistent therapeutic performance and safety.

By Mobility:The mobility segmentation includes Fixed / Stationary Systems, Portable / Mobile Systems, and Others. Fixed / Stationary Systems are the leading segment due to their widespread use in hospitals, specialized cardiology departments, and cardiac rehabilitation centers, where dedicated treatment rooms and continuous patient throughput justify larger installed systems. These systems offer stability, higher throughput, and integration with hospital monitoring infrastructure for patients undergoing treatment. However, the demand for Portable / Mobile Systems is gradually increasing as healthcare providers explore flexible solutions for satellite clinics, home-based cardiac rehabilitation, and outpatient settings, in line with Vietnam’s broader move toward proactive, community and home-based cardiovascular care. The convenience and accessibility of portable systems are appealing to both patients and providers, especially for follow-up therapy and chronic disease management.

Vietnam External Counterpulsation Devices Market Competitive Landscape

The Vietnam External Counterpulsation Devices Market is characterized by a dynamic mix of regional and international players. Leading participants such as Vaso Corporation, Renew Group Private Limited, Vasomedical Inc., ScottCare Cardiovascular Solutions, ACS Diagnostics Inc., CardioMedics Inc., Vamed Medical Instrument Co., Ltd., Shanghai Goodmed Medical Device Co., Limited, ANAND MEDITECH, and other regional EECP and cardiology device providers contribute to innovation, geographic expansion, and service delivery in this space.

Vietnam External Counterpulsation Devices Market Industry Analysis

Growth Drivers

• Increasing Prevalence of Cardiovascular Diseases:The World Health Organization reported that cardiovascular diseases (CVDs) account for approximately 33% of all deaths in Vietnam, translating to over 200,000 fatalities annually. This alarming statistic underscores the urgent need for effective treatment options, including external counterpulsation devices. As the population ages, with around 13% projected to be over 60 in future, the demand for innovative cardiovascular treatments is expected to rise significantly, driving market growth.
• Rising Awareness About Non-Invasive Treatment Options:With increasing health literacy, Vietnamese patients are becoming more aware of non-invasive treatment alternatives for cardiovascular issues. A recent survey indicated that 65% of patients prefer non-invasive methods over surgical interventions. This shift in patient preference is supported by healthcare campaigns promoting the benefits of external counterpulsation devices, which are seen as safer and more effective, thus propelling market demand in the coming years.
• Technological Advancements in Medical Devices:The Vietnamese medical device market is witnessing rapid technological advancements, with investments in R&D reaching approximately USD 150 million. Innovations in external counterpulsation technology, such as improved device efficiency and user-friendly interfaces, are enhancing treatment outcomes. As hospitals and clinics adopt these advanced devices, the market for external counterpulsation devices is expected to expand, driven by improved patient care and operational efficiency.

Market Challenges

• High Cost of Advanced Medical Devices:The average cost of advanced external counterpulsation devices in Vietnam ranges from USD 30,000 to USD 50,000, which poses a significant barrier for many healthcare facilities, especially in rural areas. This high price point limits accessibility and adoption rates, as hospitals often struggle to allocate budgets for such expensive equipment, hindering overall market growth and patient access to necessary treatments.
• Limited Reimbursement Policies:Currently, only 30% of healthcare providers in Vietnam offer reimbursement for external counterpulsation treatments, creating a financial burden for patients. The lack of comprehensive insurance coverage discourages many from seeking these non-invasive therapies, as out-of-pocket expenses can be substantial. This challenge restricts market penetration and limits the potential patient base for external counterpulsation devices in the country.

Vietnam External Counterpulsation Devices Market Future Outlook

As Vietnam's healthcare landscape evolves, the external counterpulsation devices market is poised for significant transformation. The government’s commitment to enhancing healthcare infrastructure, coupled with rising investments in medical technology, is expected to foster innovation and accessibility. Additionally, the increasing prevalence of chronic diseases will drive demand for effective treatment options. In future, the integration of telemedicine and AI in healthcare practices will further enhance patient engagement and treatment efficacy, shaping a promising future for the market.

Market Opportunities

• Expansion of Healthcare Facilities in Rural Areas:The Vietnamese government plans to invest substantially in healthcare infrastructure in future, focusing on rural areas. This initiative will increase access to advanced medical technologies, including external counterpulsation devices, thereby expanding the market reach and improving patient outcomes in underserved regions.
• Collaborations with International Medical Device Companies:Strategic partnerships with global medical device manufacturers can enhance local expertise and technology transfer. Such collaborations are expected to boost the availability of advanced external counterpulsation devices in Vietnam, fostering innovation and improving treatment options for cardiovascular diseases, ultimately benefiting the healthcare system.